Recap Of Tuesday’s Biotech Catalysts – End Of the Day Summary
Amgen (NASDAQ:AMGN) announced top-line results from the global Phase 3 CodeBreaK 200 trial evaluating once daily oral LUMAKRAS (sotorasib)…
Jaguar Health Seeks FDA Nod For Cholera Candidate Study
Jaguar Health (NASDAQ: JAGX) has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration for its subsidiary Napo's NP-300 drug product candidate for the symptomatic relief of diarrhea from cholera.
Jaguar Health Announces Submission Of IND Application To FDA For Drug Candidate For The Relief Of Diarrhea From Cholera
Jaguar is concentrating financial and management resources on two near-term late-stage clinical events
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 132 stocks hit new 52-week lows.
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 120 companies set new 52-week lows.
Recap Of Tuesday’s Biotech Catalysts – End Of the Day Summary
The U.S. Food and Drug Administration (FDA) has granted Fast Track designation for Merck‘s (NYSE:MRK) lead asset MK-2060…
12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers
ABVC BioPharma (NASDAQ:ABVC) shares increased by 12.8% to $0.97 during Monday's after-market session. The company's market cap stands at $31.6 million.
